Hypertension in Older Persons: A Systematic Review of National and International Treatment Guidelines

Journal of Clinical Hypertension

Volumn 17, Issue 6, 2015, Pages 486-492

  Alhawassi, Tariq M ^a,b   Krass, Ines ^a   Pont, Lisa G ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

^c MACQUARIE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT; ANTIHYPERTENSIVE AGENT;

AGING; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; DRUG CONTRAINDICATION; DRUG INDICATION; DRUG SAFETY; HEALTH CARE MANAGEMENT; HUMAN; HYPERTENSION; LIFESTYLE MODIFICATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; AGE; AGED; CLINICAL TRIAL (TOPIC); STANDARDS; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE DETERMINATION; CLINICAL TRIALS AS TOPIC; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC;

EID: 84931572810     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12536     Document Type: Review

References (44)

1. Pimenta E, Oparil S. Management of hypertension in the elderly. Nat Rev Cardiol. 2012;9:286-296.
2. Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA. 2005;294:466-472.
3. Hall W. Representation of blacks, women, and the very elderly (aged> or= 80) in 28 major randomized clinical trials. Ethn Dis. 1998;9:333-340.
4. Beckett NS, Peters R, Bulpitt C, et al. Treatment of hypertension in patients 80 years of age or older. N Engl J Med. 2008;358:1887-1898.
5. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA. 1991;265:3255-3264.
6. Dahlof B, Hansson L, Lindholm L, et al. STOP-hypertension: Swedish trial in old patients with hypertension. J Hypertens. 1986;4:511-513.
7. Musini VM, Tejani AM, Bassett K, et al. Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev. 2009;4:CD00028.
8. Spranger CB, Ries AJ, Berge CA, et al. Identifying gaps between guidelines and clinical practice in the evaluation and treatment of patients with hypertension. Am J Med. 2004;117:14-18.
9. Grimshaw JM, Russell IT. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993;342:1317-1322.
10. Kjeldsen S, Feldman RD, Lisheng L, et al. Updated national and international hypertension guidelines: a review of current recommendations. Drugs. 2014;74:2033-2051.
11. Al Khaja KA, Sequeira RP, Alkhaja AK, et al. Drug treatment of hypertension in pregnancy: a critical review of adult guideline recommendations. J Hypertens. 2014;32:454-463.
12. Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension. J Clin Hypertens (Greenwich). 2014;32:3-15.
13. Dasgupta K, Quinn RR, Zarnke KB, et al. The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2014;30:485-491.
14. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507-520.
15. Luehr DWT, Burke R, Dohmen F, et al. Institute for Clinical Systems Improvement. Hypertension Diagnosis and Treatment. http://www.icsi.org. Updated November 2012. Accessed February 3, 2015.
16. Sanchez RA, Ayala M, Baglivo H, et al. Latin American guidelines on hypertension. Latin American Expert Group. J Hypertens. 2009;27:905-922.
17. National Institute for Health Excellence (NICE). Hypertension: management of hypertension in adults in primary care. Clinical guideline CG127. 2011. http://www.nice.org.uk/guidance/cg127. Updated October 2013. Accessed February 3, 2015.
18. Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159-2219.
19. Shimamoto K, Ando K, Fujita T, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014). Hypertens Res. 2014;37:253-390.
20. Chiang CE, Wang TD, Li YH, et al. 2010 Guidelines of the Taiwan Society of Cardiology for the Management of Hypertension. J Formos Med Assoc. 2010;109:740-773.
21. Seedat Y, Rayner B. South African Hypertension Society. South African Hypertension Guideline 2011. S Afr Med J. 2012;102:57-84.
22. National Heart Foundation of Australia (National Blood Pressure and Vascular Disease Advisory Committee). Guide to the management of of hypertension 2008. http://www.heartfoundation.org.au. Updated December 2010. Accessed February 3, 2015.
23. Saudi Hypertension Management Group and National Commission for Hypretension. Saudi Hypertension Management Guidelines Synopsis 2011. http://www.ssfcm.org/addon/files/hypertension.pdf. Published 2011. Acessed February 3, 2015.
24. The Egyptian Hypertension Society. Egyptian Hypertension Guidelines 2014.http://ehs-egypt.net. Published 09 Jan 2015. Accessed February 3, 2015.
25. Al-Ansary LA, Tricco AC, Adi Y, et al. A systematic review of recent clinical practice guidelines on the diagnosis, assessment and management of hypertension. PLoS One. 2013;8:e53744.
26. Perry HM Jr, Smith WM, McDonald RH, et al. Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke. 1989;20:4-13.
27. Goto Y, Ishii M, Saruta T, et al. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31:2115-2127.
28. Ogihara T, Saruta T, Matsuoka H, et al. Valsartan in elderly isolated systolic hypertension (VALISH) study: rationale and design. Hypertens Res. 2004;27:657-661.
29. Chobanian AV, Bakris GL, Black HR, et al. National Heart, Lung and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the joint national committee on prevention, detection, evaluation and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
30. Staessen JA, Fagard R, Thijs L, et al. Randmised double-blind compariosn of palcebo and active treatment for older patients with isolated systolic hypertension: the Systolic Hyperension in Europe (Syst-Eur) Trial Investigators. Lancet 1997;350:757-764.
31. Weber M. Recently published hypertension guidelines of the JNC 8 Panelists, the American Society of Hypertension/International Society of Hypertension and Other Major organizations: introductions to a focus issue of the Journal of Clinical Hypertension. J Clin Hypertens (Greenwich). 2014;16:241-245.
32. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly; a report of the American College of Cardiology Foundation Task Force on Clinical Expert Cpnsensus Documents. J Am Coll Cardiol. 2011;57:2037-2114.
33. Blood PLTTC, Turnbull F, Neal B, Ninomiya T, et al. Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials. BMJ. 2008;336:1121-1123.
34. Staessen J, Fagard R, Amery A. Isolated systolic hypertension in the elderly: implications of Systolic Hypertension in the Elderly Program (SHEP) for clinical practice and for the ongoing trials. J Hum Hypertens. 1991;5:469-474.
35. Lindholm LH, Hansson L, Dahlof B, et al. The Swedish Trial in old patients with hypertension-2 (STOP-hypertension-2): a progress report. Blood Press. 1996;5:300-304.
36. Messerli FH, Grossman E, Goldbourt U. Are beta-blockers efficacious as first-line therapy for hypertension in the elderly? A systematic review. JAMA 1998;279:1903-1907.
37. Khan N, McAlister FA. Re-examining the efficacy of beta-blockers for the treatment of hypertension: a meta-analysis. Can Med Assoc J. 2006;174:1737-1742.
38. Tinetti ME, Inouye SK, Gill TM, et al. Shared risk factors for falls, incontinence, and functional dependence. Unifying the approach to geriatric syndromes. JAMA. 1995;273:1348-1353.
39. Rejnmark L. The ageing endocrine system: fracture risk after initiation of antihypertensive therapy. Nat Rev Endocrinol. 2013;9:189-190.
40. Sato I, Akazawa M. Polypharmacy and adverse drug reactions in Japanese elderly taking antihypertensives: a retrospective database study. Drug Healthc Patient Saf. 2013;5:143-150.
41. Schäfer H-H, De Villiers JN, Sudano I, et al. Recommendations for the treatment of hypertension in the elderly and very elderly-a scotoma within international guidelines. Swiss Med Wkly. 2012;142:W13574.
42. Allen M, Kelly K, Fleming I. Hypertension in elderly patients: recommended systolic targets are not evidence based. Can Fam Physician. 2013;59:19-21.
43. Mutasingwa DR, Ge H, Upshur RE. How applicable are clinical practice guidelines to elderly patients with comorbidities? Can Fam Physician. 2011;57:e253-e262.
44. Hypertension: an urgent need for global control and prevention. Lancet. 2014;383:1861.